Swing Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
353 Sacramento St Ste 1803, San Francisc...Phone Number
(619) 332-0553Website
www.swingtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Swing Therapeutics
Swing Therapeutics was founded in 2019, based out of San Francisco, CA, with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development and validation of its pipeline of prescription-based digital therapies. Swing Therapeutics' near-term goal is to validate its digital program for the treatment of fibromyalgia and bring it to market as an FDA-cleared, prescription-based digital therapeutic.Explore more
Swing Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Swing Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Swing Therapeutics
Funding: Get notified immidiatlly once Swing Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Swing Therapeutics is spiking on competitors!
Earning: See what the market has to say on Swing Therapeutics recently announced quarterly report
Product Launch: Get notified when Swing Therapeutics launches new products
Check if Swing Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Swing Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Swing Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Swing Therapeutics
Compare insights from companies similar to Swing Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Swing Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Swing Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Swing Therapeutics.
Swing Therapeutics financials insights
Gather financial insights about Swing Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$9M
2022
Series A
$10.3M
2025
Private Equity
$11.4M
Private Equity
$3.3M
Swing Therapeutics Tech Stack
A closer look at the technologies used by Swing Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Funding
Swing Therapeutics News & Media
Swing Therapeutics Announces The Lancet Publication of Data from Phase 3 Trial of Stanza™ - a Digital Behavioral Therapy for Fibromyalgia Symptoms
SAN FRANCISCO--(BUSINESS WIRE)--The smartphone-based program for fibromyalgia demonstrated significant improvements compared to an active control on virtually all endpoints.Swing Therapeutics Announces Positive Results from Pivotal Phase 3 Trial of Stanza, a Digital Therapy for Fibromyalgia Symptoms
SAN FRANCISCO--(BUSINESS WIRE)--Swing Therapeutics, a leading developer of digital therapies for chronic pain conditions, today announced the successful completion of and positive results from its pivotal Phase 3 PROSPER-FM trial on Stanza, a self-guided smartphone-based behavioral therapy for the treatment of fibromyalgia symptoms in adult patients. Results from this multi-center, randomized controlled trial (RCT) were presented at the American College of Rheumatology (ACR) 2023 annual meetingSwing Therapeutics Announces Positive Results from Studies of Stanza, a Digital Therapeutic for Fibromyalgia Treatment
SAN FRANCISCO--(BUSINESS WIRE)--Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced the presentation of research supporting the use of its digital therapeutic to deliver behavioral therapy for fibromyalgia management. Swing Therapeutics reported early results from a prospective single-arm clinical trial (REACT-FM), which were presented at the American College of Rheumatology (ACR) annual meeting lasSwing Therapeutics Closes $10.3M Series A Funding Round, Begins Enrollment in Pivotal Phase 3 Clinical Trial
SAN FRANCISCO--(BUSINESS WIRE)--Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced that it has closed a $10.3M Series A funding round led by JAZZ Venture Partners with participation by Alumni Ventures, AME Cloud Ventures, Asahi Kasei Corporate Ventures, Gaingels, Kicker Ventures, Mana Ventures, and Metrodora Ventures. The company also announced the commencement of its PROSPER-FM pivotal Phase 3 tri
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Swing Therapeutics
Sign Up For FreeTo access detailed company insights
Swing Therapeutics was founded in 2019, based out of San Francisco, CA, with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central p... Read More
